| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Feb―06 |
Dexamethasone in critical coronavirus disease-2019 cases: Insights from a cross-sectional study |
Sayuri Rocha Yamashita, Vera Lúcia Milani Martins, Victor Iury Soares Santos Patrício, Lúcia de Araújo Costa Beisl Noblat, Francine Johansson Azeredo |
| 2 |
[GO] |
2024―Mar―22 |
Identification of the essential and critical factors of decision-making for COVID-19 patient management: a mixed-method study |
Hamidreza Abtahi, Sharareh Rostam Niakan Kalhori, Amir Hossein Abooei, Moloud Taheriyan, Seyed Mohammad Ayyoubzadeh, Marsa Gholamzadeh, Elham Sadat Mousavinasab, Shahideh Amini, Mojghan Mohajeri Iravani, Alireza Bahramnejad |
| 3 |
[GO] |
2024―Feb―06 |
Effect of combination of molnupiravir with clarithromycin on blood biomarkers in patients with mild-to-moderate COVID-19 |
Kenji Gonda, Takeshi Hai, Kouichi Suzuki, Kazuki Morooka, Akihiko Ozaki, Koji Kono, Seiich Takenoshita |
| 4 |
[GO] |
2023―Mar―28 |
Acute acalculous cholecystitis as a rare gastroenterological association of COVID-19: a case series and systematic review |
|
| 5 |
[GO] |
2023―Feb―07 |
Clinical prediction model for pulmonary thrombosis diagnosis in hospitalized patients with SARS-CoV-2 infection |
|
| 6 |
[GO] |
2022―Sep―13 |
A global multi-center propensity matched analysis of mortality risk and palliative care referral due to cirrhosis in hospitalized patients with COVID-19 |
|
| 7 |
[GO] |
2022―Sep―07 |
Placental pathology, neonatal birthweight and Apgar score in acute and distant SARS-CoV-2 infection |
|
| 8 |
[GO] |
2022―Jul―25 |
The impact of chronic cardiovascular disease on COVID-19 clinical course |
|
| 9 |
[GO] |
2022―Mar―31 |
Inactivated COVID-19 vaccine triggering hemophagocytic lymphohistiocytosis in an immunocompetent adult - A case report |
|
| 10 |
[GO] |
2022―Mar―01 |
Lichen Planus drugs re-purposing as potential anti COVID-19 therapeutics through molecular docking and molecular dynamics simulation approach |
|
| 11 |
[GO] |
2022―Jan―03 |
COVID-19 associated Mucormycosis (CAM) of head and neck region: A systematic review |
|
| 12 |
[GO] |
2022―Jan―03 |
Cardiovascular involvement among collegiate athletes following COVID-19 infection |
|
| 13 |
[GO] |
2021―Oct―30 |
A review of the oresentation and outcome of left ventricular thrombus in COVID-19 infection |
|
| 14 |
[GO] |
2021―Oct―30 |
Online public interest in common malignancies & cancer screening during the COVID-19 pandemic in the United States |
|
| 15 |
[GO] |
2021―Oct―30 |
Risk of post-intubation cardiac arrest with the use of high dose rocuronium in COVID-19 patients with acute respiratory distress syndrome: A retrospective cohort study |
|
| 16 |
[GO] |
2021―Sep―29 |
Evidence for a connection between COVID-19 and exposure to radiofrequency radiation from wireless communications including 5G |
|
| 17 |
[GO] |
2021―Sep―27 |
A review of the presentation and outcome of sarcoidosis in COVID-19 |
|
| 18 |
[GO] |
2021―Aug―04 |
COVID-19 morbid pulmonary pathology: what did we learn from autopsy examinations? |
|
| 19 |
[GO] |
2021―Jul―30 |
Indonesian medical frontliners during the coronavirus disease 2019 pandemic: have we been protecting them enough? |
|
| 20 |
[GO] |
2021―Jun―05 |
Hospital length-of-stay among COVID-19 positive patients |
|
| 21 |
[GO] |
2021―Mar―24 |
COVID-19 and cardiovascular disease: a literature review |
|
| 22 |
[GO] |
2021―Mar―12 |
Addressing the global surge of COVID-19 cases: insights from diagnostics, improved treatment strategies, vaccine development and application |
|
| 23 |
[GO] |
2021―Jan―27 |
IL-13 as a target to alleviate severe COVID-19 and restore lung homeostasis |
|
| 24 |
[GO] |
2020―Dec―11 |
A box-shaped, shielding device for reducing the risk of COVID-19 droplet infection during gastrointestinal endoscopic procedures |
|
| 25 |
[GO] |
2020―Oct―21 |
The Neurological Manifestations of COVID-19 - A Case Series |
|
| 26 |
[GO] |
2020―Oct―14 |
Predicting thromboembolic complications in COVID-19 ICU patients using machine learning |
|
| 27 |
[GO] |
2020―Sep―01 |
Anti-tumor necrosis factor agents and COVID-19: A word of caution |
|
| 28 |
[GO] |
2020―Sep―01 |
Possible causes of disparities in the risk and outcomes of COVID-19: CMV and aged immune phenotype |
|
| 29 |
[GO] |
2020―Aug―18 |
Life on the frontlines: treating COVID-19 patients as an internal medicine resident physician in New York City |
|
| 30 |
[GO] |
2020―Apr―18 |
Statins as early therapy to mitigate COVID-19 (SARS-CoV-2)-associated ARDS and cytokine storm syndrome - time is of the essence |
Narci Teoh, Geoff Farrell |
